Analytical Data
-
Gene name
TAC1
- Application
-
Alternative Names
Neuromedin L Substance K
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P20366
-
Expression Region
1-129aa
-
Molecular Weight
42 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAC1, or Tachykinin-1, is a neuropeptide that plays a crucial role in various physiological processes, including pain modulation, inflammation, and neurogenic signaling. It primarily acts through its binding to neurokinin receptors, influencing numerous biological pathways. Research on TAC1 recombinant proteins has gained significant attention due to their potential applications in neuroscience and pharmacology. Understanding the structure and function of TAC1 can lead to the development of novel therapeutic strategies for pain management and other related disorders. Furthermore, TAC1's involvement in conditions such as migraine, anxiety, and depression highlights its relevance in clinical research. The ability to produce TAC1 as a recombinant protein allows scientists to study its properties in a controlled environment, facilitating insights into its mechanism of action and interactions with other cellular components. This research not only enhances our knowledge of TAC1's biological roles but also paves the way for designing targeted therapies addressing various neurological and psychiatric conditions. Given its significance, further exploration of TAC1 recombinant proteins is essential in advancing both fundamental science and applied medical research.
